Loading SaaS profile...
Loading SaaS profile...
An advanced, FDA-cleared digital treatment planning platform powered by AI that enables orthodontists and dental labs to design precise clear aligners.
Orthodontists Dental Technicians Orthodontic Lab Managers Dental Practice Owners Biomechanical Engineers
Patented TrueView machine learning algorithms deliver precise anatomical crown and root segmentation Automated CBCT and intraoral scan processing reduces case design time from hours to under two minutes Advanced dynamic collision detection and physics-based forces application ensure highly predictable staging outcomes Browser-accessible Vision Viewer application speeds up remote practitioner review pipelines and patient communication loops Flexible STL and OBJ open file structure enables frictionless integration directly with standard lab 3D printers
Category: Health & Wellness
Team Size: 26-100
Visit WebsiteSoftSmile is a specialized healthcare technology platform designed to transform the clear aligner manufacturing workflow for orthodontic clinics and digital labs. The core cloud-native application, VISION, utilizes patented machine learning algorithms and biomechanical simulations to automate tooth segmentation, staging, and collision detection. By converting standard intraoral scans into high-fidelity 3D structural dental tracks, it slashes hours of manual digital setup down to a few minutes. The solution removes traditional reliance on high-margin third-party aligner manufacturers, allowing practices to comfortably orchestrate independent in-office 3D printing grids.
SoftSmile was founded in late 2019 by Khamzat Asabaev in New York City, New York, United States. Moving away from a corporate law career advising massive international entities, Asabaev was inspired by a fellow orthodontist who was independently printing low-cost clear aligners. Recognizing that monopolized middleman distribution networks kept clear aligner therapy unaffordable for millions, they spent years with mathematicians and computer programmers perfecting advanced visual algorithms. The company achieved massive clinical validation when its core engine, VISION, received comprehensive FDA clearance in December 2021.